tbuckley/cabot-search huggingface dataset:
TCT-371 Anatomical complications and difficulties of the radial and ulnar access for percutaneous coronary interventions: analysis in more than 10,000 patients
Authors: Jorge Vitela, Victor Jimenez Diaz, Etelberto Hernandez, Pablo Juan-Salvadores, Saleta Fernández Barbeira, Antonio de Miguel, Guillermo Bastos Fernández, Alberto Ortiz Saez, Jorge SepúlvedaSepúlveda, Carlos Enrique Saldaña Luna, Giovanny Ponte, Josue Ponce, Jose Antonio Baz Alonso, Andres Iñiguez
Journal: Journal of the American College of Cardiology (2016)
UTILIDAD DE LA SECRETINA EN EL ESTUDIO MEDIANTE ECOENDOSCOPIA DE LA PATOLOGIA PANCREATOBILIAR IDIOPÁTICA RECURRENTE
Authors: L Pérez Carazo, B Merino Rodríguez, Ó Nogales Rincón, J García Lledó, M López Ibañez, E Martos Vizcaino, R Borobia Sánchez, C Carbonell Blanco, C De Gracia Fernández, C González Asanza
Journal: Endoscopy (2016)

La inyección de secretina durante la ecoendoscopia mejora la visualización del conducto pancreático principal (CPP) y optimiza el diagnóstico de su patología sin complicaciones asociadas.
Long term oxygen does not benefit patients with stable COPD, study finds
Authors: Susan Mayor
Journal: BMJ (2016)

Prescribing long term oxygen to patients with stable chronic obstructive pulmonary disease (COPD) and moderate desaturation at rest or during exercise does not extend the time to death or first admission or improve lung function or exercise capacity, a randomised trial has shown.1

Previous studies have shown that long term supplemental oxygen may reduce mortality in patients with COPD and severe resting hypoxaemia, resulting in guidelines recommending supplemental oxygen for patients with an oxyhaemoglobin saturation of less than 89%. But the benefits of long term oxygen in …
TCT-366 Predictors of major complications secondary to cardiac catheterization through femoral access in ST elevation in acute myocardial infarction during Pharmaco-Invasive Therapy
Authors: Marco Tulio Souza, Adriano Barbosa, Rodrigo Souza, Gabriel Dotta, Leonardo de Freitas Campos Guimarães, Rafael Giuberti, Manuel Pereira Marques Gomes Junior, Adriano Caixeta, Jose Marconi Almeida Sousa, Jose Souza, Antonio Carlos Carvalho, Claudia Alves
Journal: Journal of the American College of Cardiology (2016)
TCT-852 Impact of Robotics and a Suspended Lead Suit on Physician Radiation Exposure During Percutaneous Coronary Intervention
Authors: Andrew LaCombe, Andrew O'Brien, Jacob Bundy, Austin Clarey, Edwin Mandieka, Thomas Crane, David Benavides, Matthew Elmore, Abbey Mulder, Stacie VanOosterhout, Andrew Borgman, David Wohns, Ryan Madder
Journal: Journal of the American College of Cardiology (2016)
CD26+ (dipeptidyl peptidase IV positive) Cells In Harvest Material For Multiple Myeloma Autotransplantation
Authors: Anna Kopinska, Malgorzata Krawczyk-Kulis, Joanna Suszek-Dziaczkowska, Katarzyna Bieszczad, Krystyna Jagoda, Slawomira Kyrcz-Krzemien
Journal: Blood (2013)
PS01.23: Epidemiology of Neuroendocrine Tumors (NET) of the Lung in the US: Analysis of 2 Large Insurance Claims Databases
Authors: Beilei Cai, Michael S. Broder, Eunice Chang, Caroline Burk, Krzysztof J. Grzegorzewski, Maureen P. Neary
Journal: Journal of Thoracic Oncology (2016)
TCT-416 In vivo assessment of endothelial-dependent vasomotion in a coronary segment treated by the Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial
Authors: Michael Haude, Hubertus Degen, Hector Manel Garcia-Garcia, Ron Waksman, Myriam Stieler
Journal: Journal of the American College of Cardiology (2016)
Prognostic model for primary CNS lymphoma (PCNSL): Recursive partitioning analysis (RPA) of the MSKCC PCNSL population
Authors: L. E. Abrey, L. Benporat, K. S. Panageas, J. Yahalom, L. M. Deangelis
Journal: Journal of Clinical Oncology (2006)

1531 Background: Increasingly there is a need to develop a simple prognostic score that can be used in the analysis and design of PCNSL studies as well as for clinical management. Recently the IELSG published a 3 group prognostic model incorporating patient age, performance status, serum LDH, location of brain lesions and CSF total protein; however, only 105 of their 378 patients had all of the variables available to develop this score. Methods: We analyzed 338 patients (median age 60; median KPS 70) seen and treated for PCNSL at MSKCC between 1983 and 2003. The median survival was 37 months and median follow up of surviving patients is 35 months. Univariate analysis of potential prognostic factors was performed using the Kaplan Meier product limit method. Significant univariate variables were included in a multivariate analysis using the Cox proportional hazards regression model. Patients were separately analyzed using the IELSG prognostic score. Finally, RPA was employed as an independent method of developing specific prognostic categories. Results: In the univariate analysis, age, hemiparesis, mental status changes, creatinine clearance and KPS were significant predictors of overall survival; in the multivariate model only age and KPS remained as significant predictors. 113 patients had adequate information (all 5 variables) to be analyzed using the IELSG prognostic score; while this correlated significantly with overall survival, the comparison between groups 2 and 3 was not statistically significant (p = 0.10). RPA of all 338 patients identified 3 subgroups: age ≤ 50 (median OS 9.2 y), age &gt; 50 and KPS ≥ 70 (median OS 3.2 y) and age &gt; 50 and KPS &lt; 70 (median OS 1 y) that significantly separated our entire PCNSL population (p &lt; 0.001). Conclusions: The use of RPA allows for easy discrimination of 3 prognostic groups of patients with PCNSL. In contrast to the IELSG score the MSK RPA classification includes information that is readily available on all patients and can be easily incorporated into the analysis or design of clinical research. No significant financial relationships to disclose.
TCT-149 Impact of Chronic Total Occlusion in a Non-Infarct-related Artery on clinical outcomes in patients undergoing Primary Percutanous Coronary Intervention: analysis of a 8 year-all-comers prospective registry
Authors: Ana Belen Cid Alvarez, Alfredo Redondo Dieguez, Carlos Galvao Braga, Ramiro Trillo, Diego Lopez Otero, Raymundo Ocaranza-Sanchez, Belen Alvarez Alvarez, Kieran Docherty, Jose Ramon González-Juanatey
Journal: Journal of the American College of Cardiology (2016)
Public-Access Defibrillation and Out-of-Hospital Cardiac Arrest in Japan
Authors: Tetsuhisa Kitamura, Kosuke Kiyohara, Tomohiko Sakai, Tasuku Matsuyama, Toshihiro Hatakeyama, Tomonari Shimamoto, Junichi Izawa, Tomoko Fujii, Chika Nishiyama, Takashi Kawamura, Taku Iwami
Journal: New England Journal of Medicine (2016)

Early defibrillation plays a key role in improving survival in patients with out-of-hospital cardiac arrests due to ventricular fibrillation (ventricular-fibrillation cardiac arrests), and the use of publicly accessible automated external defibrillators (AEDs) can help to reduce the time to defibrillation for such patients. However, the effect of dissemination of public-access AEDs for ventricular-fibrillation cardiac arrest at the population level has not been extensively investigated.From a nationwide, prospective, population-based registry of patients with out-of-hospital cardiac arrest in Japan, we identified patients from 2005 through 2013 with bystander-witnessed ventricular-fibrillation arrests of presumed cardiac origin in whom resuscitation was attempted. The primary outcome measure was survival at 1 month with a favorable neurologic outcome (Cerebral Performance Category of 1 or 2, on a scale from 1 [good cerebral performance] to 5 [death or brain death]). The number of patients in whom survival with a favorable neurologic outcome was attributable to public-access defibrillation was estimated.Of 43,762 patients with bystander-witnessed ventricular-fibrillation arrests of cardiac origin, 4499 (10.3%) received public-access defibrillation. The percentage of patients receiving public-access defibrillation increased from 1.1% in 2005 to 16.5% in 2013 (P<0.001 for trend). The percentage of patients who were alive at 1 month with a favorable neurologic outcome was significantly higher with public-access defibrillation than without public-access defibrillation (38.5% vs. 18.2%; adjusted odds ratio after propensity-score matching, 1.99; 95% confidence interval, 1.80 to 2.19). The estimated number of survivors in whom survival with a favorable neurologic outcome was attributed to public-access defibrillation increased from 6 in 2005 to 201 in 2013 (P<0.001 for trend).In Japan, increased use of public-access defibrillation by bystanders was associated with an increase in the number of survivors with a favorable neurologic outcome after out-of-hospital ventricular-fibrillation cardiac arrest.
P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response
Authors: C. Solè, E. Sola, J. Fernandez, M. Pavesi, A. Amoros, R. Moreau, P. Angeli, R. Jalan, F. Durand, T. Gustot, F. Saliba, M. Domenicali, A. Gerbes, J. Wendon, C. Alessandria, W. Laleman, S. Zeuzem, J. Trebicka, M. Bernardi, V. Arroyo, P. Gines
Journal: Journal of Hepatology (2015)
TCT-401 Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry
Authors: Neil Ruparelia, Hiroyoshi Kawamoto, Davide Capodanno, Tommaso Gori, Holger Nef, Julinda Mehilli, Maciej Lesiak, Giuseppe Caramanno, Christoph Naber, Carlo Di Mario, Piera Capranzano, Jens Wiebe, Aleksander Araszkiewicz, Salvatore Geraci, Stelios Pyxaras, Alessio Mattesini, Thomas Munzel, Corrado Tamburino, Antonio Colombo, Azeem Latib
Journal: Journal of the American College of Cardiology (2016)
TCT-438 Outcomes After Bailout Stenting with Absorb BVS or XIENCE: Meta-analysis of Randomized Trials
Authors: Stephen Ellis, Rony Lahoud, Xiaolu Su, Robert McGreevy, Patrick Serruys, Gregg Stone, Dean Kereiakes, Run-Lin Gao, Takeshi Kimura, Yoshinobu Onuma, Wai-Fung Cheong, Jennifer Jones
Journal: Journal of the American College of Cardiology (2016)
Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression
Authors: Sanghoon Shin, Hyung-Bok Park, Hyuk-Jae Chang, Reza Arsanjani, James K. Min, Yong-Jin Kim, Byoung Kwon Lee, Jung-Hyun Choi, Geu-Ru Hong, Namsik Chung
Journal: JACC. Cardiovascular imaging (2016)
Transparency or Independence in Conflict of Interest Disclosures
Authors: Alain Braillon
Journal: JAMA Oncology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Diagnostic and Prognostic Utility of Circulating Cytochrome <i>c</i> in Acute Myocardial Infarction
Authors: Giancarlo Marenzi, Nicola Cosentino, Jasper Boeddinghaus, Mirella Trinei, Marco Giorgio, Valentina Milazzo, Marco Moltrasio, Daniela Cardinale, Maria Teresa Sandri, Fabrizio Veglia, Alice Bonomi, Max Kaech, Raphael Twerenbold, Thomas Nestelberger, Tobias Reichlin, Karin Wildi, Samyut Shrestha, Nikola Kohzuharov, Zaid Sabti, Carlo M. Cipolla, Christian Mueller, Antonio L. Bartorelli
Journal: Circulation Research (2016)

In contrast to cardiomyocyte necrosis, which can be quantified by cardiac troponin, functional cardiomyocyte impairment, including mitochondrial dysfunction, has escaped clinical recognition in acute myocardial infarction (AMI) patients.To investigate the diagnostic accuracy for AMI and prognostic prediction of in-hospital mortality of cytochrome c.We prospectively assessed cytochrome c serum levels at hospital presentation in 2 cohorts: a diagnostic cohort of patients presenting with suspected AMI and a prognostic cohort of definite AMI patients. Diagnostic accuracy for AMI was the primary diagnostic end point, and prognostic prediction of in-hospital mortality was the primary prognostic end point. Serum cytochrome c had no diagnostic utility for AMI (area under the receiver-operating characteristics curve 0.51; 95% confidence intervals 0.44-0.58; P=0.76). Among 753 AMI patients in the prognostic cohort, cytochrome c was detectable in 280 (37%) patients. These patients had higher in-hospital mortality than patients with nondetectable cytochrome c (6% versus 1%; P<0.001). This result was mainly driven by the high mortality rate observed in ST-segment-elevation AMI patients with detectable cytochrome c, as compared with those with nondetectable cytochrome c (11% versus 1%; P<0.001). At multivariable analysis, cytochrome c remained a significant independent predictor of in-hospital mortality (odds ratio 3.0; 95% confidence interval 1.9-5.7; P<0.001), even after adjustment for major clinical confounders (odds ratio 4.01; 95% confidence interval 1.20-13.38; P=0.02).Cytochrome c serum concentrations do not have diagnostic but substantial prognostic utility in AMI.
TCT-796 Highly Calcific Carotid Lesions Endovascular Revascularization Using a Novel, Dual-layer Carotid Stent System CGuardTM: Analysis from the PARADIGM Study
Authors: Adam Mazurek, Mariusz Trystuła, Jacek Jąkała, Andrzej Brzychczy, Anna Borratyńska, Agata Leśniak-Sobelga, Małgorzata Urbańczyk, R. Paweł Banyś, Wojciech Zajdel, Klaudia Proniewska, Lukasz Partyka, Krzysztof Zmudka, Piotr Podolec, Piotr Musialek
Journal: Journal of the American College of Cardiology (2016)
Preoperative chemoradiation and postoperative adjuvant tetrathiomolybdate for patients with resectable esophageal cancer
Authors: S. Urba, B. J. Schneider, J. A. Hayman, M. Orringer, A. Chang, A. Pickens, C. Pan, J. Lee, J. Foster, S. Merajver
Journal: Journal of Clinical Oncology (2009)

e15504 Background: Tetrathiomolybdate (TM) is an oral copper chelator. Copper is necessary for blood vessel growth, and so TM functions as an antiangiogenic agent. Methods: Pts with resectable esophageal cancer were treated at the University of Michigan with chemoradiation followed by surgery, and then 2 years of TM. Chemoradiation was cisplatin 60 mg/m 2 on days #1 and 22, paclitaxel 60 mg/m 2 on days #1, 8, 15, and 22, and radiation 1.5 Gy fractions b.i.d. x 3 weeks to a total of 45 Gy. Transhiatal esophagectomy was performed on approximately day #50. TM 20 mg p.o. q.d. was started approximately 4 weeks post-op, and continued for 2 years. Doses were adjusted to maintain the ceruloplasmin level between 5 and 15. Results: Between 1/23/02 and 1/24/06, 69 pts were enrolled. Pt characteristics: males - 62 (90%), females - 7 (10%); median age - 60 (range 42–74); adenocarcinoma - 56 (81%), squamous cell carcinoma 13 (19%). The chemoradiation was well tolerated: grade 3 leukopenia in 15 pts (22%), and 17 pts (25%) required feeding tubes. 66 pts went to surgery. 61 pts had a complete resection; 4 pts had metastases discovered at surgery, and 1 pt had extensive positive margins. Histologic complete response rate was 10%. 21 pts never received TM because of metastases noted in the peri-operative period, long post-op recovery time, or pt refusal. 48 pts started TM after surgery and it was well tolerated. Grade 3 toxicities were diarrhea -2 (3%), nausea - 2 (3%), dizziness - 2 (3%). 13 pts completed the full 24 mos of treatment, 12 completed 10–23 mos, 15 completed 2–8 mos, and 8 completed only 1 month or less. 27 pts have had disease recurrence, the majority (23 of the 27) of which was distant. Current status of pts with median follow-up time of 55 months: 25 alive and disease-free, 1 alive with disease, and 43 have died. 3-year survival probability is 47% (95% CI 35%-58.6%). 3-year recurrence-free probability is 51% (95% CI 38%- 62.7%). Conclusions: TM is an antiangiogenic agent which is fairly well tolerated. Prolonged adjuvant treatment over 2 years is difficult but not impossible to complete. Disease-free survival and overall survival are promising when compared to historical controls treated with a very similar chemoradiation regimen without TM in the past at the University of Michigan. [Table: see text]
Whole-Transcriptome Sequencing In Chronic Myeloid Leukemia Reveals Novel Gene Mutations That May Be Associated with Disease Pathogenesis and Progression
Authors: Simona Soverini, Angela Poerio, Alberto Ferrarini, Ilaria Iacobucci, Marco Sazzini, Joannah Score, Enrico Giacomelli, Luciano Xumerle, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti, Francesca Palandri, Gabriele Gugliotta, Marilina Amabile, Gianantonio Rosti, Michele Baccarani, Nicholas C. P. Cross, Massimo Delledonne, Giovanni Martinelli
Journal: Blood (2010)
Oral treatment of metastatic breast cancer (MBC) with capecitabine (X): What influences the decision-making process?
Authors: M. Gornas, C. Szczylik
Journal: Journal of Clinical Oncology (2007)

1111 Background: MBC may be considered a chronic disease. Many treatments require frequent clinic visits or hospitalization. Oral X is active, well tolerated, and offers several opportunities per cycle for dose adjustment. This observational study assessed patient (pt) preferences determining treatment choice. Methods: Female MBC pts eligible for X answered a questionnaire about influences on their preference for oral therapy: desire to continue their job, possibility of staying at home during treatment, more convenient way of taking medication, medical contraindications for i.v. treatment, and/or contraindication for combination therapy. Data on medical history (stage, treatment, metastatic sites) were also collected. Results: 218 questionnaires were analyzed. Median age at diagnosis was 52 years (range 27–77). Prior therapy included neoadjuvant chemotherapy (CT; 32%), surgery (93%, including 5% breast-conserving), adjuvant CT (62%), adjuvant endocrine therapy (ET; =52%), and ET for MBC (48%). X was given 1st-line for MBC in 38 pts (17%), 2nd-line in 85 (39%), and =3rd-line in 95 (44%). The most common reason for choosing oral X was more convenient form of drug delivery (154/218; 71%). 147 pts (67%) gave &gt;1 reason for choosing oral therapy. In pts with only one reason (n=71), the most common were possibility of staying at home during treatment (30/71; 42%) and more convenient form of drug (15/71; 21%). Pts receiving 2nd-line X preferred to receive drugs in a more friendly way (62/85; 73%) and stay at home during therapy (63/85; 74%). Corresponding values in pts receiving =3rd-line X were 68/95 (72%) and 53/95 (56%), respectively. Conclusions: MBC causes many psychologic and social problems. Pts prefer to receive drugs in a more friendly way at home. Therefore exploration and introduction of new, effective oral drugs into MBC treatment is vital. No significant financial relationships to disclose.
Long-Term Survival and Freedom From Reintervention After Off-Pump Coronary Artery Bypass Grafting
Authors: Bilal H. Kirmani, Michael V. Holmes, Andrew D. Muir
Journal: Circulation (2016)

Background: The long-term outcomes of off-pump coronary artery bypass grafting (CABG) are the subject of speculation. Our institution has &gt;15 years of experience performing CABG both off-pump (OPCAB) and on cardiopulmonary bypass (CPB). Our null hypothesis was that there would be no difference in a long-term composite of death and revascularisation between the 2 methods. Methods: We performed a retrospective cohort study of all isolated CABG at our institution from 2001 to 2015. We used an intention-to-treat analysis, performing risk adjustment with adjustment for and matching to propensity score. In total, 13 226 patients had CABG: 5882 had OPCAB and 7344 had CPB, with a median follow-up of 6.2 years. Results: Of the 5882 OPCAB, 76 (1.3%) converted to CPB. One-, 5-, and 10-year survivals in each group were similar (OPCAB vs CPB: 96.7%, 87.9%, 72.1% vs 96.2%, 87.4%, 72.8%). No difference was found in long-term survival (adjusted hazards ratio [HR] 1.03; 95% confidence interval [CI]: 0.94–1.11 for OPCAB vs CPB; P =0.56) or freedom from death and reintervention (HR 0.98; 95% CI: 0.92–1.06 for OPCAB vs CPB; P =0.23). Patients receiving OPCAB had higher EuroSCOREs (median [quartiles]: 2.81 [1.53–5.57] vs 2.73 [1.51–5.22]; P =0.01), fewer grafts (mean±SD: 3.0±0.9 vs 3.3±0.9; P &lt;0.001), but more total arterial grafting (45.9% vs 8.4%; P &lt;0.001). OPCAB also had more trainee first operators (15.3% vs 12.5%), lower cardiac enzyme rise, shorter length of stay, and fewer complications (such as myocardial infarction). Conclusions: OPCAB is associated with similar long-term outcomes to CABG performed on CPB in our institution. Our low conversion rate to CPB, while training junior surgeons, demonstrates that OPCAB can be taught safely. The number of grafts performed between the 2 approaches is clinically comparable, if statistically different, and appears to provide equal benefits to survival and freedom from reintervention as on-pump CABG.
TCT-266 Impact of elevated glycosylated hemoglobin (HbA1c) on admission on long-term Mortality in Patients with Unknown Diabetes Mellitus Presenting with acute myocardial infarction (STEMI or NSTEMI)
Authors: Rik Hermanides, Elvin Kedhi, Mark Kennedy, Peter van Dijk, Jorik Timmer, Jan Paul Ottervanger, Jan-Henk Dambrink, Marcel Gosselink, Vincent Roolvink, Petra Koopmans, Robbert Slingerland, Henk Bilo, Arnoud van't Hof
Journal: Journal of the American College of Cardiology (2016)
TCT-35 Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results from the CoreValve US Trial Program
Authors: James Hermiller, Sina Moainie, Steven Yakubov, Michael Reardon, Stanley Chetcuti, G. Michael Deeb, J Kevin Harrison, Jeffrey Popma, Jane Moore
Journal: Journal of the American College of Cardiology (2016)
P0767 : Clinical utility of hepatitis C virus core antigen testing in the monitoring of treatment naïve non-cirrhotic patients receiving an all-oral, interferon-free regimien
Authors: G. Cloherty, K. Cheng, S. Chevaliez, H. Wedemeyer, C. Sarrazin, J. Feld, B. Maasoumy, C. Herman, J. Hackett, G. Dawson, J.M. Pawlotsky
Journal: Journal of Hepatology (2015)
TCT-480 Regular drug eluting stents versus dedicated bifurcation drug eluting BiOSS® stents in coronary bifurcation treatment – outcome predicting factors and long-term results of two international, multicenter, randomized POLBOS I and POLBOS II clinical trials
Authors: Robert Gil, Jacek Bil, Dobrin Vassilev, Adam Kern, Natalia Pietraszek, Matylda Kaźmierska, Kamil Humaidi, Maciej Bobko, Luis A. Iñigo-Garcia, Radosław Formuszewicz, Slawomir Dobrzycki
Journal: Journal of the American College of Cardiology (2016)
High Resolution Genome-Wide Array-Based Comparative Genome Hybridization Reveals Cryptic Chromosome Changes in AML and MDS Cases with Trisomy 8 as the Sole Cytogenetic Aberration.
Authors: Kajsa Paulsson, Markus Heidenblad, Bodil Strombeck, Ake Borg, Thoas Fioretos, Bertil Johansson
Journal: Blood (2005)
Cigarette Smoking Is Associated with Increased Rates of Fungal Infection and Increased Mortality After Allogeneic Transplantation
Authors: Brian T. Hill, Brian J. Bolwell, Lisa Rybicki, Mikkael A. Sekeres, Mary Mansour, Robert Dean, Brad Pohlman, Shawnda Tench, Ronald Sobecks, Steven Andresen, Matt Kalaycio, Edward A. Copelan
Journal: Blood (2010)